{"id":5933,"date":"2025-01-20T10:03:06","date_gmt":"2025-01-20T16:03:06","guid":{"rendered":"https:\/\/nanostherapeutics.com\/?p=5933"},"modified":"2025-07-13T15:11:42","modified_gmt":"2025-07-13T20:11:42","slug":"nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference","status":"publish","type":"post","link":"https:\/\/nanostherapeutics.com\/ja\/2025\/01\/20\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\/","title":{"rendered":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u3001\u7b2c21\u56de\u5148\u9032\u6cbb\u7642\u9031\u9593\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\u3067\u767a\u8868"},"content":{"rendered":"<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<div class=\"col-sm-8 col-vcenter col-xs-12\">\n<h1><\/h1>\n<\/div>\n<div class=\"col-sm-4 col-xs-12 col-vcenter\">\n<div class=\"image logo logo-wrapper\" data-src=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg?p=publish\" data-asset-type=\"photo\" data-asset-label=\"Logo\" data-download-url=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg\" data-tweet-text=\"Nanoscope Therapeutics Logo (PRNewsfoto\/Nanoscope Therapeutics)\" data-pinterest-text=\"Nanoscope Therapeutics Logo (PRNewsfoto\/Nanoscope Therapeutics)\" data-linkedin-text=\"Nanoscope Therapeutics Logo (PRNewsfoto\/Nanoscope Therapeutics)\" data-facebook-share-text=\"Nanoscope Therapeutics Logo (PRNewsfoto\/Nanoscope Therapeutics)\" data-twitter-share-url=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg?p=twitter\" data-facebook-share-url=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg?p=facebook\" data-pinterest-share-url=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg?p=publish\" data-linkedin-share-url=\"https:\/\/mma.prnewswire.com\/media\/1333752\/Nanoscope_Therapeutics_Logo.jpg?p=linkedin\">\n<p><span class=\"legendSpanClass\"><span class=\"xn-location\">\u30c0\u30e9\u30b9<\/span><\/span>,\u00a0<span class=\"legendSpanClass\"><span class=\"xn-chron\">2025\u5e741\u670820\u65e5<\/span><\/span> \u2014\u00a0<a href=\"http:\/\/nanostherapeutics.com\/ja\/\" target=\"_blank\" rel=\"nofollow noopener\">\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u682a\u5f0f\u4f1a\u793e<\/a>\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u5bfe\u3059\u308b\u65b0\u3057\u3044\u907a\u4f1d\u5b50\u6cbb\u7642\u306e\u958b\u767a\u3068\u5546\u54c1\u5316\u306b\u3088\u308a\u3001\u73fe\u5b9f\u4e16\u754c\u3067\u5931\u660e\u3057\u305f\u60a3\u8005\u306e\u8996\u529b\u56de\u5fa9\u306b\u53d6\u308a\u7d44\u3093\u3067\u3044\u308b\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u3067\u3042\u308b\u540c\u793e\u306f\u3001\u672c\u65e5\u3001\u540c\u793e\u306e\u7d4c\u55b6\u9663\u306b\u3088\u308b\u3044\u304f\u3064\u304b\u306e\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u00a0<a href=\"https:\/\/advancedtherapiesweek.phacilitate.com\/\" target=\"_blank\" rel=\"nofollow noopener\">21<sup>\u30bb\u30f3\u30c8<\/sup>\u00a0\u00a0\u5e74\u6b21\u5148\u9032\u6cbb\u7642\u9031\u9593\u4f1a\u8b70<\/a>2025\u5e741\u670820\u65e5\u304b\u308923\u65e5\u307e\u3067\u3001\u30b1\u30a4\u30fb\u30d9\u30a4\u30ea\u30fc\u30fb\u30cf\u30c3\u30c1\u30f3\u30bd\u30f3\u30fb\u30b3\u30f3\u30d9\u30f3\u30b7\u30e7\u30f3\u30bb\u30f3\u30bf\u30fc\u3067\u958b\u50ac\u3055\u308c\u307e\u3059\u3002\u00a0<span class=\"xn-location\">\u30c6\u30ad\u30b5\u30b9\u5dde\u30c0\u30e9\u30b9<\/span>\u3002\u8b1b\u6f14\u5185\u5bb9\u306e\u8a73\u7d30\u306f\u4ee5\u4e0b\u306e\u901a\u308a\u3067\u3059\u3002<\/p>\n<p><b>\u30bf\u30a4\u30c8\u30eb\uff1a<\/b>\u00a0\u5e0c\u5c11\u75be\u60a3\u306b\u5bfe\u3059\u308b\u907a\u4f1d\u5b50\u6cbb\u7642\u306e\u8ab2\u984c\u3092\u4e57\u308a\u8d8a\u3048\u308b<b><br \/>\n\u30bb\u30c3\u30b7\u30e7\u30f3\u30bf\u30a4\u30c8\u30eb:\u00a0<\/b>\u5e0c\u5c11\u75be\u60a3\u306b\u5bfe\u3059\u308b\u907a\u4f1d\u5b50\u6cbb\u7642<br class=\"dnr\" \/><b>\u30bb\u30c3\u30b7\u30e7\u30f3\u65e5:\u00a0<\/b><span class=\"xn-chron\">2025\u5e741\u670821\u65e5<\/span><br class=\"dnr\" \/><b>\u30bb\u30c3\u30b7\u30e7\u30f3\u6642\u9593:\u00a0<\/b><span class=\"xn-chron\">\u5348\u5f8c12\u664215\u5206\uff08\u4e2d\u90e8\u6a19\u6e96\u6642\uff09<\/span><br class=\"dnr\" \/><b>\u30d7\u30ec\u30bc\u30f3\u30bf\u30fc\uff1a\u00a0<\/b><span class=\"xn-person\">\u30b5\u30de\u30ec\u30f3\u30c9\u30e9\u30fb\u30e2\u30cf\u30f3\u30c6\u30a3<\/span>, \u535a\u58eb\u53f7\u53d6\u5f97\u3001\u793e\u9577\u517c\u6700\u9ad8\u79d1\u5b66\u8cac\u4efb\u8005<\/p>\n<p>\u30e2\u30cf\u30f3\u30c6\u30a3\u535a\u58eb\u306f\u3001\u5e0c\u5c11\u75be\u60a3\u306e\u9069\u5fdc\u75c7\u306b\u5bfe\u3059\u308b\u73fe\u4ee3\u306e\u907a\u4f1d\u5b50\u6cbb\u7642\u30d7\u30ed\u30b0\u30e9\u30e0\u306e\u4e3b\u306a\u8ab2\u984c\u306b\u3064\u3044\u3066\u8aac\u660e\u3057\u307e\u3059\u3002\u3053\u308c\u306b\u306f\u3001\u9069\u5207\u306a\u52d5\u7269\u30e2\u30c7\u30eb\u3001\u78ba\u7acb\u3055\u308c\u305f\u81e8\u5e8a\u30a8\u30f3\u30c9\u30dd\u30a4\u30f3\u30c8\u3001\u691c\u8a3c\u6e08\u307f\u306e\u5206\u6790\u304a\u3088\u3073\u88fd\u9020\u30d7\u30ed\u30bb\u30b9\u306e\u4e00\u822c\u7684\u306a\u4e0d\u8db3\u304c\u542b\u307e\u308c\u307e\u3059\u304c\u3001\u307b\u3068\u3093\u3069\u306e\u5834\u5408\u3001\u3053\u308c\u3089\u306f\u907a\u4f1d\u5b50\u6cbb\u7642\u958b\u767a\u8005\u306b\u3088\u3063\u3066\u5b9f\u88c5\u3055\u308c\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002<\/p>\n<p><b>\u30bf\u30a4\u30c8\u30eb\uff1a<\/b>\u00a0\u5546\u696d\u5316\u306b\u5411\u3051\u305f\u63d0\u643a\u3001CMC\u306e\u5c55\u671b<br \/>\n<b>\u30bb\u30c3\u30b7\u30e7\u30f3\u30bf\u30a4\u30c8\u30eb:<\/b>\u00a0\u907a\u4f1d\u5b50\u6cbb\u7642\u306e\u6210\u529f\u306b\u5411\u3051\u305f\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7<br class=\"dnr\" \/><b>\u30bb\u30c3\u30b7\u30e7\u30f3\u65e5:<\/b>\u00a02025\u5e741\u670821\u65e5<br class=\"dnr\" \/><b>\u30bb\u30c3\u30b7\u30e7\u30f3\u6642\u9593:<\/b>\u00a0\u5348\u5f8c4\u664230\u5206\uff08\u4e2d\u90e8\u6a19\u6e96\u6642\uff09<br class=\"dnr\" \/><b>\u30d7\u30ec\u30bc\u30f3\u30bf\u30fc\uff1a<\/b>\u00a0\u30ec\u30a4\u30e2\u30f3\u30c9\u30fb\u30ab\u30c4\u30de\u30ec\u30af\u3001\u6700\u9ad8\u6280\u8853\u88fd\u9020\u8cac\u4efb\u8005<\/p>\n<p>\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u306e\u4e2d\u3067\u3001\u30ab\u30c4\u30de\u30ec\u30af\u6c0f\u306f\u3001\u907a\u4f1d\u5b50\u6cbb\u7642\u30d7\u30ed\u30b0\u30e9\u30e0\u306b\u304a\u3051\u308b CDMO \u95a2\u4fc2\u3068\u5168\u4f53\u7684\u306a\u88fd\u9020\u30d7\u30ed\u30b0\u30e9\u30e0\u3092\u78ba\u5b9f\u306b\u6210\u529f\u3055\u305b\u308b\u305f\u3081\u306b\u6700\u3082\u91cd\u8981\u306a\u3001\u3044\u304f\u3064\u304b\u306e\u91cd\u8981\u306a\u5185\u90e8\u304a\u3088\u3073\u5916\u90e8\u306e\u8003\u616e\u4e8b\u9805\u306b\u3064\u3044\u3066\u8aac\u660e\u3057\u307e\u3059\u3002<\/p>\n<p><b>\u30bb\u30c3\u30b7\u30e7\u30f3\u30bf\u30a4\u30c8\u30eb:\u00a0<\/b>CGT \u306e\u56fd\u969b\u7684\u53ce\u675f\u3068\u898f\u5236\u306e\u6574\u5408<br class=\"dnr\" \/><b>\u30bb\u30c3\u30b7\u30e7\u30f3\u65e5:\u00a0<\/b><span class=\"xn-chron\">2025\u5e741\u670822\u65e5<\/span><br class=\"dnr\" \/><b>\u30bb\u30c3\u30b7\u30e7\u30f3\u6642\u9593:\u00a0<\/b><span class=\"xn-chron\">\u5348\u524d11\u6642\uff08\u4e2d\u90e8\u6a19\u6e96\u6642\uff09<\/span><br class=\"dnr\" \/><b>\u6905\u5b50\uff1a\u00a0<\/b><span class=\"xn-person\">\u30ab\u30f3\u30c0\u30fc\u30f3\u30fb\u30d0\u30e9\u30c0\u30e9\u30f3<\/span>\u3001\u535a\u58eb\u3001\u898f\u5236\u304a\u3088\u3073\u54c1\u8cea\u62c5\u5f53\u4e0a\u7d1a\u526f\u793e\u9577<\/p>\n<p>\u30d0\u30e9\u30c0\u30e9\u30f3\u535a\u58eb\u306f\u3001\u535a\u58eb\u3068\u306e\u7089\u8fba\u8ac7\u8a71\u3092\u4e3b\u50ac\u3057\u307e\u3059\u3002\u00a0<span class=\"xn-person\">\u30cb\u30b3\u30fc\u30eb\u30fb\u30f4\u30a7\u30eb\u30c0\u30f3<\/span>CBER \u6cbb\u7642\u88fd\u54c1\u5c40\u306e\u30b9\u30fc\u30d1\u30fc\u30aa\u30d5\u30a3\u30b9\u30c7\u30a3\u30ec\u30af\u30bf\u30fc\u3067\u3042\u308b\u5f7c\u306f\u3001\u907a\u4f1d\u5b50\u304a\u3088\u3073\u7d30\u80de\u6cbb\u7642\u306e\u958b\u767a\u8005\u304c\u898f\u5236\u5f53\u5c40\u3068\u751f\u7523\u7684\u306a\u3084\u308a\u53d6\u308a\u3092\u7bc9\u304d\u3001\u627f\u8a8d\u307e\u3067\u306e\u52b9\u7387\u7684\u306a\u9053\u7b4b\u3092\u78ba\u4fdd\u3059\u308b\u65b9\u6cd5\u306b\u3064\u3044\u3066\u8b70\u8ad6\u3057\u307e\u3057\u305f\u3002<\/p>\n<p><b>\u30bf\u30a4\u30c8\u30eb\uff1a<\/b>\u00a0\u975e\u30a6\u30a4\u30eb\u30b9\u6027\u518d\u6295\u4e0e\u907a\u4f1d\u5b50\u6cbb\u7642\u3078\u306e\u5149\u5b66\u7684\u30a2\u30d7\u30ed\u30fc\u30c1<b><br \/>\n\u30bb\u30c3\u30b7\u30e7\u30f3\u30bf\u30a4\u30c8\u30eb:\u00a0<\/b>\u518d\u5b9f\u884c\u53ef\u80fd\u306a\u907a\u4f1d\u5b50\u6cbb\u7642\u306f\u8fd1\u3044\u5c06\u6765\u306b\u5b9f\u73fe\u3059\u308b\u304b\uff1f<br \/>\n<b>\u30bb\u30c3\u30b7\u30e7\u30f3\u65e5:\u00a0<\/b><span class=\"xn-chron\">2025\u5e741\u670822\u65e5<\/span><br class=\"dnr\" \/><b>\u30bb\u30c3\u30b7\u30e7\u30f3\u6642\u9593:\u00a0<\/b><span class=\"xn-chron\">\u5348\u524d11\u6642\uff08\u4e2d\u90e8\u6a19\u6e96\u6642\uff09<\/span><br class=\"dnr\" \/><b>\u30d7\u30ec\u30bc\u30f3\u30bf\u30fc\uff1a\u00a0<\/b><span class=\"xn-person\">\u30b9\u30d6\u30e9\u30bf\u30fb\u30d0\u30bf\u30d3\u30a2\u30eb<\/span>\u535a\u58eb\u3001\u975e\u81e8\u5e8a\u958b\u767a\u30c7\u30a3\u30ec\u30af\u30bf\u30fc<\/p>\n<p>\u30d0\u30bf\u30d3\u30e4\u30eb\u535a\u58eb\u306f\u8b1b\u6f14\u306e\u4e2d\u3067\u3001AAV\u907a\u4f1d\u5b50\u6cbb\u7642\u306b\u304a\u3051\u308b\u6295\u4e0e\u91cf\u306e\u5236\u9650\u306b\u3064\u3044\u3066\u3001\u305d\u3057\u3066\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306e\u975e\u30a6\u30a4\u30eb\u30b9\u6027\u5149\u5b66\u7684\u6295\u4e0e\u6280\u8853\u304c\u3001\u514d\u75ab\u539f\u6027\u306b\u95a2\u3059\u308b\u61f8\u5ff5\u3092\u89e3\u6d88\u3059\u308b\u3053\u3068\u3067\u3001\u3053\u306e\u5236\u9650\u3092\u3069\u306e\u3088\u3046\u306b\u514b\u670d\u3067\u304d\u308b\u304b\u306b\u3064\u3044\u3066\u8ad6\u3058\u308b\u4e88\u5b9a\u3067\u3059\u3002.<\/p>\n<p><b>\u30bf\u30a4\u30c8\u30eb\uff1a<\/b>\u00a0\u907a\u4f1d\u6027\u5931\u660e\u306b\u5bfe\u3059\u308b\u7b2c\u4e00\u9078\u629e\u907a\u4f1d\u5b50\u6cbb\u7642<b><br \/>\n<\/b><b>\u30bb\u30c3\u30b7\u30e7\u30f3\u30bf\u30a4\u30c8\u30eb:\u00a0<\/b>\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u30b7\u30ea\u30fc\u30ba\u4f01\u696d\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3<br \/>\n<b>\u30bb\u30c3\u30b7\u30e7\u30f3\u65e5:\u00a0<\/b><span class=\"xn-chron\">2025\u5e741\u670822\u65e5<\/span><br class=\"dnr\" \/><b>\u30bb\u30c3\u30b7\u30e7\u30f3\u6642\u9593:\u00a0<\/b><span class=\"xn-chron\">\u5348\u5f8c4\u6642\uff08\u4e2d\u90e8\u6a19\u6e96\u6642\uff09<\/span><br class=\"dnr\" \/><b>\u30d7\u30ec\u30bc\u30f3\u30bf\u30fc\uff1a\u00a0<\/b><span class=\"xn-person\">\u30b9\u30e9\u30cb\u30e3\u30fb\u30d0\u30bf\u30c1\u30e3\u30ea\u30e4<\/span>\u3001 \u6700\u9ad8\u7d4c\u55b6\u8cac\u4efb\u8005\uff08CEO<\/p>\n<p>\u30d0\u30bf\u30c1\u30e3\u30ea\u30e4\u6c0f\u306f\u8b1b\u6f14\u306e\u4e2d\u3067\u3001\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306e\u30d1\u30a4\u30d7\u30e9\u30a4\u30f3\u30d7\u30ed\u30b0\u30e9\u30e0\u306b\u304a\u3051\u308b\u6700\u8fd1\u306e\u9032\u6357\u72b6\u6cc1\u3068\u4eca\u5f8c\u306e\u4e88\u5b9a\u306b\u3064\u3044\u3066\u3001\u4f01\u696d\u3068\u3057\u3066\u306e\u6700\u65b0\u60c5\u5831\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u7279\u306b\u3001\u751f\u7269\u88fd\u5264\u627f\u8a8d\u7533\u8acb\uff08BLA\uff09\u304c\u4e88\u5b9a\u3055\u308c\u3066\u3044\u308b\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306e\u4e3b\u8981\u958b\u767a\u5019\u88dc\u3067\u3042\u308bMCO-010\u3001\u304a\u3088\u3073\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u793e\u306e\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\u30d7\u30ed\u30b0\u30e9\u30e0\u304c\u627f\u8a8d\u7533\u8acb\u306b\u5411\u3051\u305f\u7b2c3\u76f8\u81e8\u5e8a\u8a66\u9a13\u3078\u3068\u9032\u5c55\u3057\u305f\u3053\u3068\u306b\u3064\u3044\u3066\u8a73\u3057\u304f\u8aac\u660e\u3059\u308b\u4e88\u5b9a\u3067\u3059\u3002.<\/p>\n<p><b>\u30bf\u30a4\u30c8\u30eb\uff1a<\/b>\u00a0AAV\u907a\u4f1d\u5b50\u6cbb\u7642\u88fd\u9020\u306b\u304a\u3051\u308b\u67d4\u8edf\u6027\u3068\u62e1\u5f35\u6027\u306e\u78ba\u4fdd<b><br \/>\n\u30bb\u30c3\u30b7\u30e7\u30f3\u30bf\u30a4\u30c8\u30eb:\u00a0<\/b>\u67d4\u8edf\u6027\u3068\u62e1\u5f35\u6027\u3092\u5b9f\u73fe\u3059\u308b\u30d0\u30a4\u30aa\u30d7\u30ed\u30bb\u30b9\u30ef\u30fc\u30af\u30d5\u30ed\u30fc\u3068\u5206\u6790<br class=\"dnr\" \/><b>\u30bb\u30c3\u30b7\u30e7\u30f3\u65e5:\u00a0<\/b><span class=\"xn-chron\">2025\u5e741\u670822\u65e5<\/span><br class=\"dnr\" \/><b>\u30bb\u30c3\u30b7\u30e7\u30f3\u6642\u9593:\u00a0<\/b><span class=\"xn-chron\">\u5348\u5f8c5\u6642\uff08\u4e2d\u90e8\u6a19\u6e96\u6642\uff09<\/span><br class=\"dnr\" \/><b>\u30d7\u30ec\u30bc\u30f3\u30bf\u30fc\uff1a\u00a0<\/b><span class=\"xn-person\">\u30f4\u30a3\u30af\u30c8\u30eb\u30fb\u30a2\u30c7\u30cb\u30a4<\/span>CMC \u30b7\u30cb\u30a2\u30c7\u30a3\u30ec\u30af\u30bf\u30fc<\/p>\n<p>\u30d7\u30ec\u30bc\u30f3\u30c6\u30fc\u30b7\u30e7\u30f3\u3067\u306f\u3001Adeniyi \u6c0f\u304c\u907a\u4f1d\u5b50\u6cbb\u7642\u306b\u304a\u3051\u308b\u5206\u6790\u3068\u30b9\u30b1\u30fc\u30e9\u30d3\u30ea\u30c6\u30a3\u306e\u8ab2\u984c\u306e\u6982\u8981\u3092\u8aac\u660e\u3057\u3001\u6642\u9593\u306e\u7d4c\u904e\u3068\u3068\u3082\u306b\u3053\u308c\u3089\u306e\u8ab2\u984c\u306b\u5bfe\u51e6\u3059\u308b\u305f\u3081\u306b\u67d4\u8edf\u6027\u3092\u8a2d\u8a08\u3057\u3066\u7d44\u307f\u8fbc\u3080\u3053\u3068\u306e\u4fa1\u5024\u306b\u3064\u3044\u3066\u8aac\u660e\u3057\u307e\u3059\u3002<\/p>\n<p><b>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u306b\u3064\u3044\u3066<br class=\"dnr\" \/><\/b>\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u306f\u3001\u73fe\u5728\u6cbb\u7642\u6cd5\u304c\u5b58\u5728\u3057\u306a\u3044\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u3088\u308a\u5931\u660e\u3057\u305f\u4f55\u767e\u4e07\u4eba\u3082\u306e\u60a3\u8005\u306e\u305f\u3081\u306b\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u30aa\u30d7\u30c8\u30b8\u30a7\u30cd\u30c6\u30a3\u30c3\u30af\u7642\u6cd5\u3092\u958b\u767a\u3057\u3066\u3044\u307e\u3059\u3002\u7db2\u819c\u5909\u6027\u75be\u60a3\u306b\u5bfe\u3059\u308bRESTORE\u30d5\u30a7\u30fc\u30ba2b\u591a\u65bd\u8a2d\u30e9\u30f3\u30c0\u30e0\u5316\u4e8c\u91cd\u76f2\u691c\u507d\u5bfe\u7167\u81e8\u5e8a\u8a66\u9a13\u306e\u826f\u597d\u306a\u8a66\u9a13\u7d42\u4e86\u7d50\u679c\u3092\u53d7\u3051\u3066\uff08<a href=\"https:\/\/c212.net\/c\/link\/?t=0&l=en&o=4344147-1&h=2306890774&u=https%3A%2F%2Fclinicaltrials.gov%2Fstudy%2FNCT04945772&a=NCT04945772\" target=\"_blank\" rel=\"nofollow noopener\">NCT04945772<\/a>\uff09\u3001\u540c\u793e\u306f\u3001\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&l=en&o=4344147-1&h=3410968068&u=https%3A%2F%2Fnanostherapeutics.com%2F2024%2F10%2F10%2Fnanoscope-announces-plans-to-submit-bla-for-mco-010-to-treat-retinitis-pigmentosa%2F&a=BLA+submission+for+MCO-010+to+treat+RP\" target=\"_blank\" rel=\"nofollow noopener\">RP\u6cbb\u7642\u85acMCO-010\u306eBLA\u7533\u8acb<\/a>\u00a0\u540c\u793e\u306f\u3001\u30b9\u30bf\u30fc\u30ac\u30eb\u30c8\u75c5\u60a3\u8005\u3092\u5bfe\u8c61\u3068\u3057\u305fMCO-010\u7642\u6cd5\u306e\u7b2c2\u76f8STARLIGHT\u8a66\u9a13\u3092\u5b8c\u4e86\u3057\u305f\uff08<a href=\"https:\/\/c212.net\/c\/link\/?t=0&l=en&o=4344147-1&h=1646865510&u=https%3A%2F%2Fclinicaltrials.gov%2Fstudy%2FNCT05417126&a=NCT05417126\" target=\"_blank\" rel=\"nofollow noopener\">NCT05417126<\/a>\uff09\u3092\u958b\u59cb\u3057\u3001\u00a0<a href=\"https:\/\/c212.net\/c\/link\/?t=0&l=en&o=4344147-1&h=1616213576&u=https%3A%2F%2Fnanostherapeutics.com%2F2024%2F09%2F12%2Fnanoscope-therapeutics-announces-end-of-phase-2-meeting-with-u-s-fda-and-plan-to-initiate-a-phase-3-clinical-trial-of-mco-010-to-treat-stargardt-macular-degeneration%2F&a=Phase+3+registrational+trial\" target=\"_blank\" rel=\"nofollow noopener\">\u30d5\u30a7\u30fc\u30ba3\u767b\u9332\u8a66\u9a13<\/a>\u00a02025\u5e74\u7b2c1\u56db\u534a\u671f\u306b\u767a\u58f2\u4e88\u5b9a\u3067\u3059\u3002MCO-010\u306f\u3001RP\u3068Stargardt\u306e\u4e21\u65b9\u3067FDA\u30d5\u30a1\u30b9\u30c8\u30c8\u30e9\u30c3\u30af\u6307\u5b9a\u3068FDA\u5e0c\u5c11\u75be\u75c5\u7528\u533b\u85ac\u54c1\u6307\u5b9a\u3092\u53d7\u3051\u3066\u3044\u307e\u3059\u3002\u524d\u81e8\u5e8a\u30d7\u30ed\u30b0\u30e9\u30e0\u306b\u306f\u3001IND\u5bfe\u5fdc\u306eGA\u5411\u3051\u975e\u30a6\u30a4\u30eb\u30b9\u6027\u30ec\u30fc\u30b6\u30fc\u9001\u9054MCO-020\u8cc7\u7523\u3068\u3001IND\u5bfe\u5fdc\u7814\u7a76\u4e2d\u306eLeber\u5148\u5929\u6027\u9ed2\u5185\u969c\u5411\u3051AAV\u8cc7\u7523\u304c\u542b\u307e\u308c\u307e\u3059\u3002<\/p>\n<p><b>\u6295\u8cc7\u5bb6\u9023\u7d61\u5148:<\/b><br class=\"dnr\" \/>\u30a2\u30eb\u30b4\u30c3\u30c8\u30d1\u30fc\u30c8\u30ca\u30fc\u30ba<br class=\"dnr\" \/>212-600-1902<br class=\"dnr\" \/><a href=\"mailto:PR@nanostherapeutics.com\" target=\"_blank\" rel=\"nofollow noopener\">PR@nanostherapeutics.com<\/a><\/p>\n<p>\u51fa\u5178 \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9<\/p>\n<p><img decoding=\"async\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=DA00067&Transmission_Id=202501201030PR_NEWS_USPR_____DA00067&DateId=20250120\" alt=\"\" \/><\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>DALLAS,\u00a0Jan. 20, 2025 \u2014\u00a0Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real-world settings by developing and commercializing novel gene therapies for retinal degenerative diseases, today announced several presentations by company leadership at the\u00a021st\u00a0\u00a0Annual Advanced Therapies Week Conference, taking place from\u00a0January 20-23, 2025 at the\u00a0Kay Bailey Hutchinson Convention Center in\u00a0Dallas, Texas. Details for the presentations are as follows: Title:\u00a0Navigating the Challenges of Gene Therapies for Rare Diseases Session Title:\u00a0Gene Therapy for Rare DiseaseSession Date:\u00a0January 21, 2025Session Time:\u00a012:15 p.m. C.T.Presenter:\u00a0Samarendra Mohanty, PhD, President &#038; Chief Scientific Officer Dr. Mohanty will discuss key challenges to modern gene therapy programs for rare disease indications. These will include the [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":5934,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[13,8],"tags":[],"class_list":["post-5933","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-home-page","category-nanoscope-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanoscope Therapeutics to Present at the 21st Annual Advanced Therapies Week Conference - Nanoscope Therapeutics<\/title>\n<meta name=\"description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanostherapeutics.com\/ja\/2025\/01\/20\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\/\" \/>\n<meta property=\"og:locale\" content=\"ja_JP\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanoscope Therapeutics to Present at the 21st Annual Advanced Therapies Week Conference - Nanoscope Therapeutics\" \/>\n<meta property=\"og:description\" content=\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanostherapeutics.com\/ja\/2025\/01\/20\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanoscope Therapeutics\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-20T16:03:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-13T20:11:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/01\/NSCOPE_LinkedIn_ADVTHERA25.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1920\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Nanoscope Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/01\/NSCOPE_LinkedIn_ADVTHERA25.jpg\" \/>\n<meta name=\"twitter:creator\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:site\" content=\"@NSTherapeutics\" \/>\n<meta name=\"twitter:label1\" content=\"\u57f7\u7b46\u8005\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nanoscope Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593\" \/>\n\t<meta name=\"twitter:data2\" content=\"4\u5206\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/01\\\/20\\\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/01\\\/20\\\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\\\/\"},\"author\":{\"name\":\"Nanoscope Therapeutics\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\"},\"headline\":\"Nanoscope Therapeutics to Present at the 21st Annual Advanced Therapies Week Conference\",\"datePublished\":\"2025-01-20T16:03:06+00:00\",\"dateModified\":\"2025-07-13T20:11:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/01\\\/20\\\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\\\/\"},\"wordCount\":638,\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/01\\\/20\\\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/NSCOPE_LinkedIn_ADVTHERA25.jpg\",\"articleSection\":[\"Home Page\",\"Nanoscope Press Release\"],\"inLanguage\":\"ja\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/01\\\/20\\\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/01\\\/20\\\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\\\/\",\"name\":\"Nanoscope Therapeutics to Present at the 21st Annual Advanced Therapies Week Conference - Nanoscope Therapeutics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/01\\\/20\\\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/01\\\/20\\\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/NSCOPE_LinkedIn_ADVTHERA25.jpg\",\"datePublished\":\"2025-01-20T16:03:06+00:00\",\"dateModified\":\"2025-07-13T20:11:42+00:00\",\"description\":\"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/01\\\/20\\\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\\\/#breadcrumb\"},\"inLanguage\":\"ja\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/01\\\/20\\\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/01\\\/20\\\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/NSCOPE_LinkedIn_ADVTHERA25.jpg\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/01\\\/NSCOPE_LinkedIn_ADVTHERA25.jpg\",\"width\":1920,\"height\":1920},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/2025\\\/01\\\/20\\\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nanostherapeutics.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nanoscope Therapeutics to Present at the 21st Annual Advanced Therapies Week Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#website\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"name\":\"Nanoscope Therapeutics\",\"description\":\"Bringing Back the Light of Hope\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\"},\"alternateName\":\"Nanoscope Therapeutics\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanostherapeutics.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ja\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#organization\",\"name\":\"Nanoscope Therapeutics, Inc\",\"alternateName\":\"Nanoscope Therapeutics\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ja\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"contentUrl\":\"https:\\\/\\\/nanostherapeutics.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/NSCOPE_Logo_Stack_2Color_512.png\",\"width\":512,\"height\":435,\"caption\":\"Nanoscope Therapeutics, Inc\"},\"image\":{\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/NSTherapeutics\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/nanoscope\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nanostherapeutics.com\\\/#\\\/schema\\\/person\\\/5aeedc9aef0946fe8f96f98f7b1808a2\",\"name\":\"Nanoscope Therapeutics\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u7b2c21\u56de\u5148\u9032\u6cbb\u7642\u9031\u9593\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\u3067\u767a\u8868\u3078 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanostherapeutics.com\/ja\/2025\/01\/20\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\/","og_locale":"ja_JP","og_type":"article","og_title":"Nanoscope Therapeutics to Present at the 21st Annual Advanced Therapies Week Conference - Nanoscope Therapeutics","og_description":"Our multi-characteristic opsin (MCO) platform is the first to demonstrate an ability to restore vision to retinal disease patients with severe vision loss in clincial trials. Nanoscope has developed MCO-010, the first and only broad spectrum, fast response and ultra-sensitive optogenetic technology for vision restoration that is gene-agnostic.","og_url":"https:\/\/nanostherapeutics.com\/ja\/2025\/01\/20\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\/","og_site_name":"Nanoscope Therapeutics","article_published_time":"2025-01-20T16:03:06+00:00","article_modified_time":"2025-07-13T20:11:42+00:00","og_image":[{"width":1920,"height":1920,"url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/01\/NSCOPE_LinkedIn_ADVTHERA25.jpg","type":"image\/jpeg"}],"author":"Nanoscope Therapeutics","twitter_card":"summary_large_image","twitter_image":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/01\/NSCOPE_LinkedIn_ADVTHERA25.jpg","twitter_creator":"@NSTherapeutics","twitter_site":"@NSTherapeutics","twitter_misc":{"\u57f7\u7b46\u8005":"Nanoscope Therapeutics","\u63a8\u5b9a\u8aad\u307f\u53d6\u308a\u6642\u9593":"4\u5206"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nanostherapeutics.com\/2025\/01\/20\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\/#article","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/2025\/01\/20\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\/"},"author":{"name":"Nanoscope Therapeutics","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2"},"headline":"Nanoscope Therapeutics to Present at the 21st Annual Advanced Therapies Week Conference","datePublished":"2025-01-20T16:03:06+00:00","dateModified":"2025-07-13T20:11:42+00:00","mainEntityOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2025\/01\/20\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\/"},"wordCount":638,"publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2025\/01\/20\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/01\/NSCOPE_LinkedIn_ADVTHERA25.jpg","articleSection":["Home Page","Nanoscope Press Release"],"inLanguage":"ja"},{"@type":"WebPage","@id":"https:\/\/nanostherapeutics.com\/2025\/01\/20\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\/","url":"https:\/\/nanostherapeutics.com\/2025\/01\/20\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e\u3001\u7b2c21\u56de\u5148\u9032\u6cbb\u7642\u9031\u9593\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9\u3067\u767a\u8868\u3078 - \u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","isPartOf":{"@id":"https:\/\/nanostherapeutics.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nanostherapeutics.com\/2025\/01\/20\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\/#primaryimage"},"image":{"@id":"https:\/\/nanostherapeutics.com\/2025\/01\/20\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/01\/NSCOPE_LinkedIn_ADVTHERA25.jpg","datePublished":"2025-01-20T16:03:06+00:00","dateModified":"2025-07-13T20:11:42+00:00","description":"\u5f53\u793e\u306e\u591a\u6a5f\u80fd\u30aa\u30d7\u30b7\u30f3\uff08MCO\uff09\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u306b\u304a\u3044\u3066\u91cd\u5ea6\u306e\u8996\u529b\u55aa\u5931\u3092\u4f34\u3046\u7db2\u819c\u75be\u60a3\u60a3\u8005\u306e\u8996\u529b\u3092\u56de\u5fa9\u3055\u305b\u308b\u80fd\u529b\u3092\u5b9f\u8a3c\u3057\u305f\u521d\u306e\u30d7\u30e9\u30c3\u30c8\u30d5\u30a9\u30fc\u30e0\u3067\u3059\u3002Nanoscope\u793e\u306f\u3001\u907a\u4f1d\u5b50\u306b\u4f9d\u5b58\u3057\u306a\u3044\u3001\u5e83\u7bc4\u56f2\u306e\u30b9\u30da\u30af\u30c8\u30eb\u3001\u9ad8\u901f\u5fdc\u7b54\u6027\u3001\u8d85\u9ad8\u611f\u5ea6\u3092\u5099\u3048\u305f\u3001\u8996\u529b\u56de\u5fa9\u306e\u305f\u3081\u306e\u6700\u521d\u3067\u552f\u4e00\u306e\u5149\u907a\u4f1d\u5b66\u6280\u8853\u3067\u3042\u308bMCO-010\u3092\u958b\u767a\u3057\u307e\u3057\u305f\u3002.","breadcrumb":{"@id":"https:\/\/nanostherapeutics.com\/2025\/01\/20\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\/#breadcrumb"},"inLanguage":"ja","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanostherapeutics.com\/2025\/01\/20\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\/"]}]},{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/2025\/01\/20\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\/#primaryimage","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/01\/NSCOPE_LinkedIn_ADVTHERA25.jpg","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/01\/NSCOPE_LinkedIn_ADVTHERA25.jpg","width":1920,"height":1920},{"@type":"BreadcrumbList","@id":"https:\/\/nanostherapeutics.com\/2025\/01\/20\/nanoscope-therapeutics-to-present-at-the-21st-annual-advanced-therapies-week-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nanostherapeutics.com\/"},{"@type":"ListItem","position":2,"name":"Nanoscope Therapeutics to Present at the 21st Annual Advanced Therapies Week Conference"}]},{"@type":"WebSite","@id":"https:\/\/nanostherapeutics.com\/#website","url":"https:\/\/nanostherapeutics.com\/","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9","description":"\u5e0c\u671b\u306e\u5149\u3092\u53d6\u308a\u623b\u3059","publisher":{"@id":"https:\/\/nanostherapeutics.com\/#organization"},"alternateName":"Nanoscope Therapeutics","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanostherapeutics.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ja"},{"@type":"Organization","@id":"https:\/\/nanostherapeutics.com\/#organization","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9\u793e","alternateName":"Nanoscope Therapeutics","url":"https:\/\/nanostherapeutics.com\/","logo":{"@type":"ImageObject","inLanguage":"ja","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","contentUrl":"https:\/\/nanostherapeutics.com\/wp-content\/uploads\/2025\/03\/NSCOPE_Logo_Stack_2Color_512.png","width":512,"height":435,"caption":"Nanoscope Therapeutics, Inc"},"image":{"@id":"https:\/\/nanostherapeutics.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/NSTherapeutics","https:\/\/www.linkedin.com\/company\/nanoscope"]},{"@type":"Person","@id":"https:\/\/nanostherapeutics.com\/#\/schema\/person\/5aeedc9aef0946fe8f96f98f7b1808a2","name":"\u30ca\u30ce\u30b9\u30b3\u30fc\u30d7\u30fb\u30bb\u30e9\u30d4\u30e5\u30fc\u30c6\u30a3\u30af\u30b9"}]}},"_links":{"self":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5933","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/comments?post=5933"}],"version-history":[{"count":2,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5933\/revisions"}],"predecessor-version":[{"id":9007,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/posts\/5933\/revisions\/9007"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media\/5934"}],"wp:attachment":[{"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/media?parent=5933"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/categories?post=5933"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nanostherapeutics.com\/ja\/wp-json\/wp\/v2\/tags?post=5933"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}